Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,615.88
(
1.68%
)
US TECH 100
23,723.20
(
1.89%
)
Dow Jones
46,469.51
(
1.96%
)
Brent Oil
97.39
(
-9.93%
)
Bitcoin
70,576.65
(
4.04%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 153054

Tuesday, 11/27/2012 3:54:13 PM

Tuesday, November 27, 2012 3:54:13 PM

Post# of 257269
According to GILD’s PR, 15% of the patients randomized to the non-placebo arm had cirrhosis. The SVR12 rate among these cirrhotic patients was 61%; however, GILD did not disclose the breakdown of cirrhotic patients by genotype as they did for the overall trial.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today